期刊文献+

儿童膜增生性肾炎5例临床病理分析 被引量:2

Clinical and pathological characteristics of membranoproliferative glomerulonephritis:A report of 5 cases
下载PDF
导出
摘要 目的 进一步提高对膜增生性肾炎的病理及临床的认识,探讨治疗方法。方法 对5例病理诊断为膜增生性肾炎患儿的病理、临床表现特点、治疗转归进行分析。结果 ①5例临床表现为肾病水平的蛋白尿及血尿, 4例有高血压, 2例肾功不全;②病理改变肾小球系膜细胞增生及系膜基质扩张, 3例肾小球呈分叶状, 2例有新月体形成, 4例基膜“双轨征”,肾间质有不同程度的损害,免疫荧光均以C3 沉积为主;③5例均应用了泼尼松治疗,其中3例应用了甲基泼尼松龙冲击, 4例联合应用了环磷酰胺静脉冲击治疗。3例获部分缓解, 1例完全缓解, 1例呈持续肾病状态。结论 儿童膜增生性肾小球肾炎临床表现以肾炎型肾病为主。病理以系膜细胞增生基质扩张和基膜“双轨征”为其特征性改变,免疫荧光检查以C3沉积为主。大剂量激素联合环磷酰胺静脉冲击治疗对短期内缓解病情、改善肾功能是有效的。 ObjectiveTo understand the clinical and pathological characteristics of the membranoproliferative glomerulonephritis (MPGN) and to explore the therapeutic methods. Methods The clinical characteristics, laboratory data, pathological findings and therapeutic methods were investigated retrospectively in the 5 patients with MPGN (aged 8-13 years). Results ①All five patients presented with nephritic-range proteinuria (>50 mg/kg· d) and haematuria, 4 patients had hypertension and low serum C_3 levels; and 2 patients, azotemia. ②Renal biopsies revealed mesangial hypercellularety and expanded mesangial matrix in 5 cases, glomerular lobulation, in 3 cases, and crescent formation, in 2 cases. The double contour of basement membrane occurred in 4 cases. Different degrees of tubulointerstitial damage occurred in 5 cases. Immunofluoroscence showed C_3 deposition in 5 cases. ③ All the 5 patients received prednisone combined with intravenous cyclophosplamide (CTX ) alone or added methyprednisolone together with pulse therapy. After treatment, 1 patient achieved a complete remission; 3, partial remission, and persistent nephropathy in 1 case. Conclusions The study suggested that clinical manifestation in children with MPGN is characterized by nephritic nephrosis. The pathological changes are characterized by mesangial cells proliferation, expanded mesangial matrix and double contour of basement membrance. High dosage corticosteroids combined with CTX pulse therapy may be effective for improving the short outcome of MPGN.
出处 《中国当代儿科杂志》 CAS CSCD 2005年第2期128-130,共3页 Chinese Journal of Contemporary Pediatrics
关键词 膜增生性肾炎 肾炎型肾病 甲基强泼尼松 环磷酰胺 儿童 Membranoproliferative glomerulonephritis Nephritic nephrosis Methyprednisolone Cyclophosplamide Child
  • 相关文献

参考文献8

  • 1Madala ND, Naicker S, Singh B, Naidoo M, Smith AN, Rughubar K. The pathogenesis of membranoproliferative glomerulonephritis in KwaZulu-Natal, South Africa is unrelated to hepatitis C virus infection[ J]. Clin Nephrol, 2003 ,60(2) :69-73.
  • 2中华医学会儿科学分会肾脏病学组,姚勇,杨霁云,陈述枚,丁洁.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39(12):746-749. 被引量:1533
  • 3Ronald J, Falk J, Charles J, Nachman PH. Primary Glomernlar Disease. In: Brenner BM, ed. Brenner&Rector's the Kidney [ M ].6th ed. Beijing: Beijing Science Press, 2001,1263-1350..
  • 4White RHR. Membranoproliferatine Glomerulonephritis. In: Edelmann CM, ed. Pediatric Kidney Disease[M]. 1st ed, Vol 2.Boston: Little, 1978,660-679.
  • 5杨霁云,膜增生性肾炎.见:杨霁云,白克敏.小儿肾脏病基础与临床[M],北京:人民卫生出版社,2000,181-186.
  • 6王海燕.系膜毛细血管性肾炎.见:王海燕.肾脏病学[M].第2版,北京:人民卫生出版社,1997,671-681.
  • 7张红景.膜增生性肾小球肾炎.见:董德长.实用肾脏病学[M],上海:上海科技出版社,1999,507-511.
  • 8胡玲.系膜增殖性肾小球肾炎患儿α-平滑肌肌动蛋白表达与血脂及血压的关系探讨[J].中国当代儿科杂志,2002,4(2):106-108. 被引量:1

二级参考文献3

  • 1Stephenson LA, Haney LB,Hussaini IM,et al. Regulation of smooth muscle α-actin expression and hypertrophy in cultured mesangial cells [J] .Kidney Int,1998,54(4):1175-1187.
  • 2Nishida Y, Yorioka N, Oda H, et al.Effect of lipoproteins on cultured human mesangial cells [J] .Am J Kid Dis,1997,29(6): 919-930.
  • 3Hamaguchi A, Kim S, Ohta K, et al.Transforming growth factor-β1 expression and phenotypic modulation in the kidney of hypertensive rats [J] .Hypertension, 1995,26(1):199-207.

共引文献1532

同被引文献17

  • 1刘宏伟.膜增殖性肾炎的中医证治探讨[J].辽宁中医杂志,1995,22(5):201-202. 被引量:3
  • 2<环孢素A在肾内科的应用>专家协作组.环孢素A治疗肾小球疾病的应用共识[J].中华肾脏病杂志,2005,21(9):556-557. 被引量:74
  • 3朱美凤.麻金木辨治膜增生性肾小球肾炎验案[J].江西中医药,2007,38(5):10-11. 被引量:1
  • 4Bergstein JM, Andreoli SP. Response of type mesangioproliferative glomerulonephritis to pulsemethylprednisolone and alternate day prednisone therapy. Pediatr Nephrol, 1995,9 (3) :268 ~ 271.
  • 5Jones G, Juszczak M, Kingdon E, et al. Treatment of idiopathic membranoproliferative g|omerulonephritis with mycophenolate mofetil and steroids. Nephrol Dial Transplant,2004,19:3160 ~ 3164.
  • 6陈伊伦,王慧萍,陈江华.半剂量强的松合用普乐可复治疗膜增生性肾小球肾炎疗效初步观察.中华医学会第11届全国内科学术会议论文汇编.2007.396.
  • 7Donadio IV, Anderson CF, Mitche HJC, et al. Membranoproliferative glomemlonephritis. A prospective clinical trial of platelet - inhibitor therapy. N Engl J Med,1984,310(22) :1421.
  • 8Richard JH Smith, Jessy Alexander, Paul N Barlow, et al. New approaches to the treatment of dense deposit disease. Journal of the American Society of Nephrology ,2007,18:2447 ~ 2456.
  • 9李学旺,杨军,李航,段琳,黄庆元,毕增祺.环孢素A治疗难治性肾病综合征[J].中华内科杂志,1998,37(5):315-319. 被引量:39
  • 10夏正坤,刘光陵,高远赋,樊忠民,伏洁,傅元凤,何旭.他克莫司在儿童原发性肾病综合征中的应用[J].中华肾脏病杂志,2009,25(3):187-190. 被引量:31

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部